• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 4 filed by Arena Fortify Sponsor Llc

    12/20/22 5:00:34 PM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous
    Get the next $AFAC alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
    X
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
    1. Name and Address of Reporting Person*
    Arena Fortify Sponsor LLC

    (Last) (First) (Middle)
    C/O ARENA FORTIFY ACQUISITION CORP.
    405 LEXINGTON AVENUE, 59TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Arena Fortify Acquisition Corp. [ AFAC ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director X 10% Owner
    Officer (give title below) X Other (specify below)
    See Remarks
    3. Date of Earliest Transaction (Month/Day/Year)
    12/20/2022
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Class B Common stock (1) 12/20/2022 D(2) 3,591,000(2) (1) (1) Class A common stock 3,591,000 $0.00(2) 0 D(2)
    Class B common stock (1) 12/20/2022 D(3) 37,500(3) (1) (1) Class A common stock 37,500 $0.00(3) 0 D(3)
    1. Name and Address of Reporting Person*
    Arena Fortify Sponsor LLC

    (Last) (First) (Middle)
    C/O ARENA FORTIFY ACQUISITION CORP.
    405 LEXINGTON AVENUE, 59TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Goodwin Kieran

    (Last) (First) (Middle)
    C/O ARENA FORTIFY ACQUISITION CORP.
    405 LEXINGTON AVENUE, 59TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Crockard James E III

    (Last) (First) (Middle)
    C/O ARENA FORTIFY ACQUISITION CORP.
    405 LEXINGTON AVENUE, 59TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    McCarthy Marc T

    (Last) (First) (Middle)
    C/O ARENA FORTIFY ACQUISITION CORP.
    405 LEXINGTON AVENUE, 59TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    ZWIRN DANIEL B

    (Last) (First) (Middle)
    C/O ARENA FORTIFY ACQUISITION CORP.
    405 LEXINGTON AVENUE, 59TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    Edmonds Franklin S. Jr.

    (Last) (First) (Middle)
    C/O ARENA FORTIFY ACQUISITION CORP.
    405 LEXINGTON AVENUE, 59TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    1. Name and Address of Reporting Person*
    White Gregory Campbell

    (Last) (First) (Middle)
    C/O ARENA FORTIFY ACQUISITION CORP.
    405 LEXINGTON AVENUE, 59TH FLOOR

    (Street)
    NEW YORK NY 10174

    (City) (State) (Zip)
    Explanation of Responses:
    1. The shares of Class B common stock ("Class B Shares") would have automatically converted into shares of the Issuer's Class A common stock at the time of the Issuer's initial business combination, or earlier at the option of the subject holder, on a one-for-one basis, with no expiration date.
    2. In connection with the liquidation and dissolution of the Issuer, Arena Fortify Sponsor LLC ("Sponsor") surrendered to the Issuer, for no consideration, 3,591,000 Class B Shares directly held by Sponsor. Kieran Goodwin is the president and manager of Sponsor, and had sole voting and dispositive power over the securities of the Issuer surrendered by Sponsor, and therefore may have been deemed to have had beneficial ownership of the securities of the Issuer held directly by Sponsor. Mr. Goodwin disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
    3. In connection with the liquidation and dissolution of the Issuer, each of James Crockard III and Marc McCarthy surrendered to the Issuer, for no consideration, 18,750 Class B Shares directly held by such reporting persons.
    Remarks:
    This "Exit" Form 4 is filed to report that, following the Issuer's dissolution on December 20, 2022, each of the Reporting Persons is no longer subject to Section 16 reporting.
    Arena Fortify Sponsor LLC, By: /s/ Kieran Goodwin, Name: Kieran Goodwin, Title: Manager 12/20/2022
    Kieran Goodwin, By: /s/ Kieran Goodwin 12/20/2022
    James Crockard III, By: /s/ Kieran Goodwin, as Attorney-in-Fact 12/20/2022
    Marc McCarthy, By: /s/ Kieran Goodwin, as Attorney-in-Fact 12/20/2022
    Daniel Zwirn, By: /s/ Kieran Goodwin, as Attorney-in-Fact 12/20/2022
    Franklin S. Edmonds Jr., By: /s/ Kieran Goodwin, as Attorney-in-Fact 12/20/2022
    Gregory White, By: /s/ Kieran Goodwin, as Attorney-in-Fact 12/20/2022
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $AFAC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AFAC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AFAC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arena Fortify Acquisition Corp. Obtains Stockholder Approval to Terminate Before Year-End

    NEW YORK, New York, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Arena Fortify Acquisition Corp. (the "Company") held a special meeting of stockholders on December 8, 2022, at 8:00 a.m., Eastern Time, as a completely virtual meeting, conducted over the internet via live audio webcast with no physical in-person meeting (the "Special Meeting"). At this Special Meeting, stockholders approved certain amendments (collectively, the "Charter Amendment") to the Company's amended and restated certificate of incorporation (the "Charter") to, among other things, allow the Company to amend the date by which the Company must consummate a business combination from February 15, 2023 to December 9, 2022 (such date,

    12/9/22 8:17:10 PM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous

    $AFAC
    SEC Filings

    View All

    SEC Form 15-12G filed by Arena Fortify Acquisition Corp.

    15-12G - Arena Fortify Acquisition Corp. (0001849489) (Filer)

    12/19/22 4:13:03 PM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous

    Arena Fortify Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Arena Fortify Acquisition Corp. (0001849489) (Filer)

    12/9/22 9:39:00 PM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous

    SEC Form 25-NSE filed by Arena Fortify Acquisition Corp.

    25-NSE - Arena Fortify Acquisition Corp. (0001849489) (Subject)

    12/8/22 4:09:21 PM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous

    $AFAC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Arena Fortify Sponsor Llc

    4 - Arena Fortify Acquisition Corp. (0001849489) (Issuer)

    12/20/22 5:00:34 PM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous

    $AFAC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)

    SC 13G/A - Arena Fortify Acquisition Corp. (0001849489) (Subject)

    2/14/23 7:49:42 AM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous

    SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)

    SC 13G/A - Arena Fortify Acquisition Corp. (0001849489) (Subject)

    1/31/23 3:18:39 PM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous

    SEC Form SC 13G/A filed by Arena Fortify Acquisition Corp. (Amendment)

    SC 13G/A - Arena Fortify Acquisition Corp. (0001849489) (Subject)

    1/25/23 8:02:32 AM ET
    $AFAC
    Other Pharmaceuticals
    Miscellaneous